• 9964432222
  • Mail Us
  • Appointment
  • Locate Us
  • Chat Now
  • Courses
  • Login
  • Register
Manifest IAS
JournalsOfIndia
Advertisement
  • Home
  • Economy
  • Foreign Affairs
  • Science & Tech
  • Environment
  • Law & Policy
  • History
No Result
View All Result
  • Home
  • Economy
  • Foreign Affairs
  • Science & Tech
  • Environment
  • Law & Policy
  • History
No Result
View All Result
JournalsOfIndia
No Result
View All Result
Home Science & Tech

Oxford vaccine- AZD1222

January 1, 2021
in Science & Tech, Society
Reading Time: 2min read
0
Oxford vaccine- AZD1222
83
VIEWS
Share on TelegramShare on Facebook

In news

The United Kingdom approved the Oxford vaccine recently

About Oxford vaccine

  • The Oxford-AstraZeneca vaccine has been approved for use in the UK
  • AZD1222, also known as ChAdOx1 nCoV-19, is a COVID-19 vaccine developed by Oxford University and AstraZeneca given by intramuscular injection, using as a vector the modified chimpanzee adenovirus ChAdOx1.
  • The AZD1222 vaccine is a replication-deficient simian adenovirus vector, containing the full‐length codon‐optimized coding sequence of SARS-CoV-2 spike protein along with a tissue plasminogen activator (tPA) leader sequence.
  • The researchers used the SARS-CoV-2 genome that had been sequenced in Wuhan
  • Unlike the Pfizer and Moderna vaccines, the ‘Oxford vaccine’ doesn’t require sub-zero refrigeration and is reportedly more conducive to be distributed in India.
  • AstraZeneca aims to supply millions of doses in the first quarter as part of an agreement with the government to supply up to 100 million doses in total.
  • Both AstraZeneca and Pfizer have been approved in the U.K. and the U.S. respectively after they publicised data from their ongoing phase-3 trials.
  • The Pfizer-BioNTech jab’s trials showed two full doses were 95% effective at preventing infection, while the Oxford-AstraZeneca vaccine showed 62% effectiveness – although even in cases where people were infected, there were no cases of serious illness needing hospital treatment.
  • Oxford-AstraZeneca vaccine’s trials also showed that when people were given a half dose then a full dose, effectiveness hit 90%.
  • It uses a chimpanzee viral vector based on a weakened version of a common cold virus (adenovirus) that causes infections in chimpanzees and contains the genetic material of the SARS-CoV-2 virus spike protein

Significance of approval for India

  • This is significant for India, as the Pune-based Serum Institute of India (SII) has tied up with AstraZeneca to deploy the vaccine in the country.
  • After the recent approval, the country’s drug regulator has said that it reviewed an application by the SII for ‘emergency use authorization (EUA).
Source: The Hindu & BBC
Tags: Prelims

Related Posts

Aquaponics

Aquaponics

January 25, 2021
Holography

Holography

January 25, 2021
Factor D Protein: Covid-19

Factor D Protein: Covid-19

January 25, 2021
Smart Anti-Airfield Weapon (SAAW)

Smart Anti-Airfield Weapon (SAAW)

January 23, 2021
Agriculture and Biotechnology

Agriculture and Biotechnology

January 21, 2021
India innovation Index 2020

India innovation Index 2020

January 20, 2021
New Covid tongue symptoms

New Covid tongue symptoms

January 20, 2021
Chandra x ray captures image of a supernova

Chandra x ray captures image of a supernova

January 20, 2021
Monsoon Forecast Models

Monsoon Forecast Models

January 20, 2021
Chabahar port

Chabahar port

January 19, 2021
Please login to join discussion

Browse by Category

  • Agriculture
  • Disaster Management
  • Economy
  • Environment
  • Ethics
  • Foreign Affairs
  • Geography
  • Governance
  • History
  • Law & Policy
  • Opinion
  • People in News
  • Places in News
  • Science & Tech
  • Security
  • Society

Browse by Tags

AIR Big Picture Down to Earth GS-1 GS-2 GS-3 GS-4 Kurukshetra Mains News Paper PIB Prelims RSTV Spotlight on AIR Yojana
JournalsOfIndia

Our vision is to orient the readers to grasp the facts objectively and analyse critically. In the rush of reaching first to the readers, the websites miss the balanced opinion, which is the need of the hour. We aim to reach the readers with more crispness, preciseness and relevance. We bring the articles in UPSC way for the civil services aspirants and the Wisest Way for general readers.

Categories

  • Agriculture
  • Disaster Management
  • Economy
  • Environment
  • Ethics
  • Foreign Affairs
  • Geography
  • Governance
  • History
  • Law & Policy
  • Opinion
  • People in News
  • Places in News
  • Science & Tech
  • Security
  • Society

Browse by Tag

AIR Big Picture Down to Earth GS-1 GS-2 GS-3 GS-4 Kurukshetra Mains News Paper PIB Prelims RSTV Spotlight on AIR Yojana

Newsletter

The most important UPSC news and events of the day.

Get Journals daily newsletter on your inbox.

© 2020 JournalsOfIndia - A free initiative by Manifest Team.

  • Login
  • Sign Up
  • Home
  • Prelims Snippets
  • Mains Articles
  • Economy
  • Society
  • Foreign Affairs
  • Science & Tech
  • Environment
  • Agriculture
  • History
  • Law & Policy
  • Security
  • Course Portal
  • Prelims Test Portal
No Result
View All Result

© 2020 JournalsOfIndia - A free initiative by Manifest Team.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In